Episode 463
How to find reliable health information, weight loss drug research, and GLP-1 side effects
What is the most trusted medical information source? Is semaglutide safe? What is the best treatment for obesity? How long can you be on semaglutide for weight loss? Our guest is Kirsten Bibbins-Domingo, MD, PhD, editor-in-chief of JAMA and the JAMA Network. American Medical Association CXO Todd Unger hosts.
May 24, 202412m 3s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
What is the most trusted medical information source? Is semaglutide safe? What is the best treatment for obesity? How long can you be on semaglutide for weight loss?
Our guest is Kirsten Bibbins-Domingo, MD, PhD, editor-in-chief of JAMA and the JAMA Network. American Medical Association CXO Todd Unger hosts.
Topics
medicinefuture of healthcarejama networkamerican medical associationhealthcare aiobesity treatmentclinical studyhealthcareweight loss drugsweight lossmisinformationwegovymedical journaldigital healthjama network openphysician advocacydrug side effectsmedical researchsemaglutide semaglutide side effectsfighting for docsnatural weight losspublic healthpatient caremedicalhealth informationjama studyozempickffjamahealthcare innovationjama datasciencemedical misinformationglp1medical information